Information about Lagevrio® (Molnupiravir)

Which best describes you?

For information in another country

Based outside of the United Kingdom? Click on the link below to view information for the other countries

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://coronavirus-yellowcard.mhra.gov.uk for how to report side effects.

GB-ANV-00014 | Date of Preparation: January 2026